Loading...
Guest User
Welcome! Please login.
| IPO Listing At | BSE SME |
| SME IPO Issue Type | Fixed Price Issue |
| Total Issue Size | ₹5.78 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹5.78 Cr |
| Fresh Issue | ₹5.48 Cr |
| Face Value | ₹10 Per Equity Share |
| Issue Price | ₹96.00 per share |
| Discount | Retail: 0.00 |
| BSE Code | 544220 |
| Registrar | Bigshare Services Pvt.Ltd. |
| Lead Managers | Inventure Merchant Banker Services... |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 1,200 shares and in multiples thereof
Founded in 1990, Clinitech Laboratory Limited provides diagnostic and health testing and services.
The company performs more than 150 tests in its centres, which are divided into different categories: Biochemical Tests, Immunology Tests, Hematology Tests, Molecular Biology Tests, Serology Tests, Microbiology Tests and Histopathology Tests.
Clinitech Laboratory has eight diagnostic centres around Thane and Navi Mumbai. The company conducts more than 3 lakh tests per year in its NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited laboratories equipped with modern technology and high quality equipment.
The company's medical testing facilities at Airoli, Navi Mumbai, have been accredited by NABL (National Accreditation Board for Testing and Calibration Laboratories) as per ISO 15189:2012.
As of May 31, 2024, the company employed 85 people in various departments.
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Expansion of Diagnostic Centres | 4.99 |
| 2 | General Corporate Purposes | 0.41 |
| Period Ended | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 5.61 | 6.03 | 3.69 | 2.73 |
| Total Income | 6.44 | 6.36 | 6.46 | 4.60 |
| Profit After Tax | 0.37 | 0.61 | 0.51 | 0.40 |
| NET Worth | 3.55 | 2.38 | 1.85 | 1.39 |
| Reserves and Surplus | 1.87 | 0.88 | 0.35 | 0.72 |
| Total Borrowing | 0.86 | 1.03 | 0.89 | 0.54 |
| Amount in ₹ Crore | ||||
| KPI | Mar 31, 2024 |
|---|---|
| Debt / Equity | 0.24% |
| RoNW | 10.46% |
| PAT Margin | 5.76% |
| Price to Book Value | 4.55 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 2.21 | 1.63 |
| P/E (x) | 43.45 | 59.03 |
| Promoter Holding | 83.65% | 61.57% |
| Market Cap | ₹21.91 Cr. | |
